Early determinants of atherosclerosis in paediatric systemic lupus erythematosus

被引:0
|
作者
Boros, C. A. [1 ,6 ,9 ]
Bradley, T. J. [2 ,9 ]
Cheung, M. M. H. [2 ,9 ]
Bargman, J. M. [5 ,7 ]
Russell, J. L. [2 ,9 ]
McCrindle, B. W. [2 ,9 ]
Adeli, K. [3 ]
Hamilton, J. [4 ,9 ]
Silverman, E. D. [1 ,6 ,8 ,9 ]
机构
[1] Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada
[3] Hosp Sick Children, Div Clin Biochem, Toronto, ON M5G 1X8, Canada
[4] Hosp Sick Children, Div Endocrinol, Toronto, ON M5G 1X8, Canada
[5] Toronto Gen Hosp, Div Nephrol, Toronto, ON, Canada
[6] Univ Toronto, Dept Biochem, Toronto, ON, Canada
[7] Univ Toronto, Dept Med, Toronto, ON, Canada
[8] Univ Toronto, Dept Immunol, Toronto, ON, Canada
[9] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada
关键词
vascular testing; cardiovascular risk factors; lipids; insulin resistance; LOW-DENSITY-LIPOPROTEIN; RISK-FACTORS; ACCELERATED ATHEROSCLEROSIS; MYOCARDIAL-PERFUSION; YOUNG-ADULTS; WOMEN; CHILDREN; DISEASE; HOMOCYSTEINE; PROGRESSION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To assess traditional and non-traditional cardiovascular risk factors and to determine the prevalence and correlates of early vascular markers of atherosclerosis in paediatric systemic lupus erythematosus (pSLE). Methods Fifty-four adolescents with pSLE had cardiovascular risk factor assessment, disease activity and vascular testing including carotid intima-media thickness (CIMT), flow-mediated dilatation (FMD), arterial stiffness measures, and myocardial perfusion studies. Results The traditional risk factors of hypertension, elevated triglycerides, apolipoprotein B, haemoglobin AI c and insulin levels and non-traditional risk factors of elevated homocysteine and fibrinogen were present (all p<0.001). Some arterial stiffness measures, central pulse wave velocity and characteristic impedance were elevated (p<0.001), but CIMT, FMD and myocardial perfusion were normal. Cumulative prednisone dose correlated with total cholesterol (r=0.5790, p<0.001) and elevated LDL-C (r=0.4488, p=0.0012). Hydroxychloroquine treatment correlated negatively with total cholesterol (r=-0.4867, p=0.0002), LDL-C (r=-0.4805, p=0.0002) and apolipoprotein B (r=-0.4443, p=0.0011). In multivariate analysis LDL-C correlated with cumulative prednisone dose and negatively with hydroxychloroquine treatment (R-2=0.40, p<0.001). Conclusions An increased burden of traditional and non-traditional risk factors and early evidence of insulin resistance and increased central arterial stiffness were present in paediatric SLE. Disease-specific and therapy-related factors are likely modifying these cardiovascular risk profiles warranting prospective longitudinal studies.
引用
收藏
页码:575 / 581
页数:7
相关论文
共 50 条
  • [31] Insulin resistance in systemic lupus erythematosus patients: contributing factors and relationship with subclinical atherosclerosis
    Sanchez-Perez, H.
    Tejera-Segura, B.
    de Vera-Gonzalez, A.
    Gonzalez-Delgado, A.
    Olmos, J. M.
    Hernandez, J. L.
    Corrales, A.
    Lopez-Mejias, R.
    Gonzalez-Gay, M. A.
    Ferraz-Amaro, I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (06) : 885 - 892
  • [32] Antiphospholipid Antibodies and Atherosclerosis: Insights from Systemic Lupus Erythematosus and Primary Antiphospholipid Syndrome
    Ames, Paul R. J.
    Margarita, Annamaria
    Alves, Jose Delgado
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2009, 37 (01) : 29 - 35
  • [33] Impact of Disease Duration on Vascular Surrogates of Early Atherosclerosis in Childhood-Onset Systemic Lupus Erythematosus
    Barsalou, Julie
    Bradley, Timothy J.
    Tyrrell, Pascal N.
    Slorach, Cameron
    Ng, Lawrence W. K.
    Levy, Deborah M.
    Silverman, Earl D.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (01) : 237 - 246
  • [34] Gastrointestinal and hepatic involvement in paediatric systemic lupus erythematosus
    Trapani, S.
    Rubino, C.
    Simonini, G.
    Indolfi, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (04) : 899 - 906
  • [35] Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis
    Marks, Stephen D.
    Tullus, Kjell
    ACTA PAEDIATRICA, 2010, 99 (07) : 967 - 974
  • [36] Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis
    Wu, Guo-Cui
    Liu, Hai-Rong
    Leng, Rui-Xue
    Li, Xiang-Pei
    Li, Xiao-Mei
    Pan, Hai-Feng
    Ye, Dong-Qing
    AUTOIMMUNITY REVIEWS, 2016, 15 (01) : 22 - 37
  • [37] Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus
    Kiani, Adnan N.
    Post, Wendy S.
    Magder, Laurence S.
    Petri, Michelle
    RHEUMATOLOGY, 2011, 50 (11) : 2071 - 2079
  • [38] Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis
    Sharma, S. K.
    Rathi, M.
    Sahoo, S.
    Prakash, M.
    Dhir, V.
    Singh, S.
    LUPUS, 2016, 25 (05) : 525 - 531
  • [39] The association between adipokines and stigmata of atherosclerosis in patients with systemic lupus erythematosus
    Rezaieyazdi, Zahra
    Mirfeizi, Zahra
    Hatef, Mohammad Reza
    Gholami, Golnaz
    Sedighy, Sima
    Esmaily, Habibollah
    Azarpazhooh, Mahmoud Reza
    Karimani, Asieh
    Salari, Masoumeh
    EGYPTIAN RHEUMATOLOGIST, 2020, 42 (03) : 195 - 199
  • [40] Subclinical carotid atherosclerosis in a patient with systemic lupus erythematosus
    Alpert, Deborah
    Davis, Adrienne
    Erkan, Doruk
    Roman, Mary J.
    Salmon, Jane E.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (08): : 473 - 478